Latest filing published 20 Aug 2015 for AIM ImmunoTech Inc., €3,994.
Insider track record
No signal scores available.
Closed purchases
Based on 14 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +6.2%Entry US$8,193.99 · Close at T+365 US$8,706.11
- -0.0%Entry US$8,706.11 · Close at T+365 US$8,706.11
- -22.2%Entry US$9,218.23 · Close at T+365 US$7,169.74
- -39.1%Entry US$11,778.86 · Close at T+365 US$7,169.74
- -41.7%Entry US$12,290.98 · Close at T+365 US$7,169.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William A. Carter: trading record in brief
William A. Carter discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). Between 1 December 2006 and 20 August 2015, the trades on record add up to 36 filings.
Both buying and selling appear: 14 purchases worth €700k, against 4 sales worth €142k. Purchases outweigh sales by €558k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 8 share grants. So far in 2015, the count stands at 7 purchases and no sales.
A typical purchase (the median) is worth €8,565. For 14 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 29% of cases, with a median move of -16.7%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 20 August 2015: an open-market purchase of €3,994, in AIM ImmunoTech Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William A. Carter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$0.1795Common StockSEC:0001008161-15-000007:0Canonical exit: 18 Nov 2015 (T+90)
- 25,000 shares@ US$0.182Common StockSEC:0001008161-15-000006:0Canonical exit: 16 Nov 2015 (T+90)
- 25,000 shares@ US$0.1815Common StockSEC:0001008161-15-000005:0Canonical exit: 15 Nov 2015 (T+90)
- 100,000 shares@ US$0.242Common StockSEC:0001008161-15-000004:0Canonical exit: 27 Jul 2015 (T+90)
- 100,000 shares@ US$0.24Common StockSEC:0001008161-15-000003:0Canonical exit: 20 Jul 2015 (T+90)
- 73,681 shares@ US$0.23Common StockSEC:0001008161-15-000002:0Canonical exit: 16 Jul 2015 (T+90)
- 26,319 shares@ US$0.23Common StockSEC:0001008161-15-000001:0Canonical exit: 15 Jul 2015 (T+90)
- 20,000 shares0Common StockSEC:0001008161-13-000001:0
- 10,000 shares0Common StockSEC:0001008161-12-000008:0
- 10,000 shares0Common StockSEC:0001008161-12-000007:0
- 818,682 shares@ US$0.4948Common StockSEC:0001008161-10-000007:0Canonical exit: 8 Nov 2010 (T+90)
- 125,630 shares@ US$0.502Common StockSEC:0001008161-10-000007:1
- 224,110 shares@ US$0.4924Common StockSEC:0001008161-10-000007:2
- 26,519 shares@ US$0.481Common StockSEC:0001008161-10-000007:3
- 2,144 shares@ US$0.4968Common StockSEC:0001008161-10-000007:4Canonical exit: 8 Nov 2010 (T+90)
- 1,129 shares@ US$0.4968Common StockSEC:0001008161-10-000007:5
- 500,000 shares@ US$0.66Common StockSEC:0001008161-10-000005:0Canonical exit: 9 Sept 2010 (T+90)
- 10,813 shares0Common StockSEC:0001008161-10-000004:0
- 5,000 shares0Common StockSEC:0001008161-10-000003:0
- 5,000 shares0Common StockSEC:0001008161-10-000002:0
- 20,000 shares0Common StockSEC:0001008161-10-000001:0
- 30,000 shares@ US$0.569Common StockSEC:0001008161-09-000001:0Canonical exit: 7 Mar 2010 (T+90)
- 3,630 shares0Common stockSEC:0000946644-09-000029:0
- 14,900 shares0Common stockSEC:0000946644-09-000026:0
- 65,376 shares@ US$0.42Incentive sharesSEC:0000946644-09-000021:0
25 of 33 declarations